Polybatics closer to commercialising ‘magic bullet’

Last updated 11:07 24/11/2009

Relevant offers


Former GNS Science chief executive was highest-earning CRI boss on $800,000 Banker involved in alleged mortgage fraud fights for name suppression Cloud computing: get with it or get left behind Australian deal triggers option for NZME to acquire 3000 advertising panels Young have biggest reservations about the 'pros and cons' of the internet Mad Butcher Tauranga in liquidation after months of poor trading World Bank names NZ best country for business WorkSafe to investigate trampoline parks after rise in injuries No simple link between media competition and story choice, says US professor Job listings on Seek spike in September as big retailers open stores

Polybatics, a biotech start-up, is edging closer to commercializing a process for delivering custom payloads into living cells, potentially giving medical specialists a nanotechnology weapon to target disease.

The Palmerston North-based company, perched in a business park alongside Massey University, designs and manufactures natural bionanoparticles. These 'biobeads,' as they are known, can carry a range of proteins including antibodies, enzymes and antigens into living tissue. 

Massey University Professor of Microbiology Bernd Rehm developed the technology which uses a natural polymer granule produced by bacteria under stress. Polybatics was set up to commercialise the research, gaining a $1 million grant this year and with plans to seek a further tranche in 2010.

The company now needs to demonstrate that biobeads can be scaled up from its laboratory proof-of-concept. 

One demonstration was attaching tuberculosis antigens to the biobeads and eliciting a response against the disease in mice. Applications of the biobeads and attached functional proteins include bioseparations, antibody production and purification, diagnostics, antigen delivery, biocatalysts and drug delivery, said managing director Tracy Thompson. 

Polybatics has one global patent and three pending. The company has four secondees from Massey and Canterbury universities. They will become full-time employees and receive stock options "when the time is appropriate," said Thompson. 

"It's not quite time for them to quit their university jobs," he said. 


Ad Feedback
Special offers

Featured Promotions

Sponsored Content